Oncogenic and ligand-dependent activation of KIT/PDGFRA in surgical samples of imatinib-treated gastrointestinal stromal tumours (GISTs).

Negri, T

Oncogenic and ligand-dependent activation of KIT/PDGFRA in surgical samples of imatinib-treated gastrointestinal stromal tumours (GISTs). [electronic resource] - The Journal of pathology Jan 2009 - 103-12 p. digital

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

1096-9896

10.1002/path.2450 doi


Antineoplastic Agents--therapeutic use
Benzamides
Gastrointestinal Stromal Tumors--drug therapy
Humans
Imatinib Mesylate
Neoadjuvant Therapy
Piperazines--therapeutic use
Platelet-Derived Growth Factor--metabolism
Proto-Oncogene Proteins c-kit--metabolism
Pyrimidines--therapeutic use
Receptor, Platelet-Derived Growth Factor alpha--metabolism
Signal Transduction
Stem Cell Factor--metabolism